Egetis Therapeutics AB: Egetis granted a rolling NDA review by FDA for Emcitate (tiratricol) based on currently available clinical data

The outcomes of a successful pre-NDA meeting with the FDA are: As agreed with the FDA, the rolling NDA submission will commence in December 2025, targeting a complete NDA submission in early 2026 and ...

Medication 'incidents' involving kids reported every two days at Glasgow hospitals

A Freedom of Information Request revealed that since 2020, there have been 1,216 recorded incidents of errors, near misses or ...
The Daily Cardinal

The Tylenol Crisis and RFK Jr.’s weaponization of science

Trump and RFK Jr.’s claims linking Tylenol to autism are false, spread fear, and undermine trust in public health. This ...
24/7 Tempo on MSN

Pharmacists Share the Medication Myths and Truths They Wish Everyone Knew

If you think your pharmacist can’t offer much guidance on your prescriptions, think again. While they don’t attend medical ...